组织清理市场－全球产业规模、份额、趋势、机会、预测：按产品、应用、类型、最终用途、地区和竞争对手划分，2021-2031年

全球组织透明度市场预计将从 2025 年的 1.3249 亿美元成长到 2031 年的 1.8041 亿美元，复合年增长率为 5.28%。

这项技术透过去除光散射脂质来清除生物检体的杂质，从而实现对完整细胞结构的三维成像。推动此成长要素包括神经退化性疾病发生率的上升以及药物研发中对高解析度3D成像的需求。生命科学领域的大量资金支持也为这项技术的进步提供了保障。例如，欧洲製药工业协会联合会（EFPIA）在2024年发布的报告显示，製药业已在欧洲研发领域投资约550亿欧元，凸显了这些先进技术获得了强而有力的资金支持。

然而，更广泛的市场扩张面临的主要障碍在于如何管理和分析成像产生的大量资料集。处理从透明化检体中获得的Terabyte资料需要高效能运算资源，而小规模实验室往往缺乏这种资源。这些与资料储存和复杂影像重建相关的技术限制，阻碍了组织透明化通讯协定的广泛应用及其与标准诊断流程的整合。

市场驱动因素

神经系统疾病和神经退化性疾病的日益普遍是推动组织透明化技术应用的主要动力。科学家迫切需要解读脑损伤的复杂立体结构。传统的二维组织学方法往往不足以捕捉到理解阿兹海默症疾病所需的复杂神经连结和空间背景。组织透明化技术能够实现全脑成像，从而可以全面观察淀粉样斑块和Tau蛋白纤维的定位。根据阿兹海默症协会于2024年3月发布的《2024年阿兹海默症现况》报告，约有690万65岁及以上的美国人患有老年痴呆症失智症，这显示一场巨大的公共卫生危机推动了这项研究的迫切需求。

同时，高解析度显微镜和成像技术的进步显着提升了组织透明化方法的实用性和价值。现代共聚焦显微镜和光片显微镜专为处理大型透明样本而设计，能够以细胞内水平的精度获取体积数据。这一发展得益于产业的持续创新。具体而言，卡尔蔡司医疗技术股份公司（Carl Zeiss Meditec AG）于2024年12月发布的《2023/24年度报告》明确指出，公司已投入3.431亿欧元用于研发，重点致力于改进视觉化工具。此外，布鲁克公司（Bruker）在2024年公布的财务业绩也表明，其2023财年全年销售额达29.6亿美元，这充分体现了全球对生命科学解决方案和科学仪器的强劲需求。

市场挑战

处理和分析大量资料集是全球组织透明化市场成长的主要障碍。虽然组织透明化技术能够视觉化整个生物系统，但由此产生的高解析度3D影像会为每个样本产生Terabyte级的复杂、非结构化资料。如此庞大的资料量会使标准实验室系统不堪重负，储存和重建的难度也造成了瓶颈，超过了样本生成能力。因此，这些技术难以在小规模研究机构中应用，市场成长仅限于拥有先进运算能力的资源丰富的研究中心。

数位基础设施的这种差距严重阻碍了市场的广泛应用。影像处理对高效能运算的依赖造成了资料生成与其实际应用之间的脱节，阻碍了关键试剂和设备的获取。根据2024年Pistoia Alliance的一项调查，54%的生命科学专业人士认为管理非结构化资料是高效实验研究的主要障碍。由于组织透明化过程几乎全部产生大规模非结构化影像数据，这项产业普遍面临的挑战直接降低了新用户的潜在投资回报，减缓了组织透明化解决方案的商业性扩张。

市场趋势

组织透明化和空间转录组学的融合是市场发展的一个重大趋势，它将研究从构造成像转向在完整的三维环境下进行详细的分子分析。这项进展使科学家能够在保留细胞间相互作用空间关係的同时绘製蛋白质分布和基因表现图谱，这对于发育生物学和免疫学的发展至关重要。开发相容的空间分析工具的公司数量激增，证明了这种多组体学策略的商业性成功。例如，10x Genomics 在 2024 年 2 月发布的 2023 年第四季和全年财务报告中显示，其全年收入为 6.187 亿美元，这主要得益于其基于先进组织製备技术的太空生物学平台的广泛应用。

同时，将组织透明化技术应用于高通量3D球状体和类器官模型，尤其是在药物研发流程中，已成为显着的趋势。与用于解剖图谱绘製的全器官透明化不同，这一趋势侧重于快速处理微组织，以便在生理上精确的肿瘤模型中评估药物的毒性和疗效。这种方法将体外筛检与临床结果联繫起来，而癌症的严重负担使得这种关联的需求日益凸显。根据美国癌症协会于2024年1月发布的《2024年癌症事实与数据》报告，预计2024年美国将新增超过200万例癌症病例，凸显了预测性非临床模型对于加速开发有效癌症治疗方法的重要性。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球组织清算市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依产品类别（仪器、试剂盒/试剂、服务）
  • 按应用领域（神经学、肿瘤学、心臟科等）
  • 按类型（软组织、硬组织）
  • 按应用领域（学术研究、产业界）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美组织透明化市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国别分析
  • 我们
  • 加拿大
  • 墨西哥

第七章：欧洲组织清算市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国别分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区组织清算市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国别分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲组织清算市场展望

• 市场规模及预测
• 市占率及预测
• 中东与非洲：国别分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲组织清算市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国别分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 促进因素
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 近期趋势

第十三章：全球组织清算市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的议价能力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Logos Biosystems
• Visikol, Inc.
• LifeCanvas Technologies
• Miltenyi Biotec
• Bio-Techne
• Abcam plc
• ClearLight Biotechnologies, Inc.
• FUJIFILM Corporation
• Thermo Fisher Scientific, Inc.
• Corning Incorporated

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Tissue Clearing Market is projected to expand from USD 132.49 Million in 2025 to USD 180.41 Million by 2031, reflecting a compound annual growth rate of 5.28%. This technique involves making biological specimens transparent by extracting light-scattering lipids, enabling the volumetric imaging of intact cellular frameworks. Key growth drivers include the rising incidence of neurodegenerative conditions and the necessity for high-resolution three-dimensional mapping in drug development. This progress is supported by significant life sciences funding; for instance, the European Federation of Pharmaceutical Industries and Associations reported in 2024 that the pharmaceutical sector invested approximately €55,000 million in European research and development, underscoring the strong financial support for these advanced tools.

Nevertheless, the broader expansion of the market faces a major obstacle in managing and analyzing the immense datasets resulting from imaging. Processing terabytes of data from cleared specimens demands high-performance computing resources that are often unavailable in smaller labs. This technical constraint related to data storage and complex image reconstruction restricts the widespread use of tissue clearing protocols and hinders their incorporation into standard diagnostic procedures.

Market Driver

The rising prevalence of neurological and neurodegenerative disorders serves as a major driver for tissue clearing adoption, as scientists urgently need to decode the complex three-dimensional structures of brain pathologies. Conventional 2D histology is often insufficient for capturing the intricate neural connections and spatial context needed to understand diseases such as Alzheimer's. Tissue clearing facilitates whole-brain imaging, offering a complete view of amyloid plaques and tau tangles in situ. According to the Alzheimer's Association's "2024 Alzheimer's Disease Facts and Figures" report from March 2024, approximately 6.9 million Americans aged 65 and older are living with Alzheimer's dementia, emphasizing the massive scale of the public health crisis fueling this research demand.

At the same time, improvements in high-resolution microscopy and imaging technologies have greatly increased the practicality and value of tissue clearing methods. Modern confocal and light-sheet microscopes are now designed to accommodate large, transparent samples, allowing for the capture of volumetric data with subcellular precision. This evolution is driven by ongoing industry innovation; specifically, Carl Zeiss Meditec AG noted in its December 2024 "Annual Report 2023/24" that €343.1 million was allocated to research and development, highlighting a commitment to improved visualization tools. Additionally, the financial strength of manufacturers is evident, as Bruker Corporation reported full-year 2023 revenues of $2.96 billion in 2024, indicating robust global demand for life science solutions and scientific instruments.

Market Challenge

The handling and analysis of massive datasets present a significant obstacle to the growth of the Global Tissue Clearing Market. Although tissue clearing techniques facilitate the visualization of whole biological systems, the resulting high-resolution three-dimensional images create terabytes of complex, unstructured data for each sample. This immense volume overloads standard laboratory systems, resulting in a bottleneck where storage and reconstruction difficulties exceed sample generation capabilities. As a result, smaller research facilities are discouraged from utilizing these methods, effectively confining market growth to well-resourced centers equipped with advanced computational power.

This gap in digital infrastructure severely hinders wider market adoption. The dependence on high-performance computing for image processing causes a disconnect between data creation and its practical application, stalling the acquisition of essential reagents and equipment. According to the Pistoia Alliance in 2024, 54% of life science professionals cited the management of unstructured data as a major impediment to efficient experimental research. Since tissue clearing produces almost entirely large-scale unstructured image data, this sector-wide challenge directly lowers the potential return on investment for new users, thereby retarding the commercial expansion of tissue clearing solutions.

Market Trends

A major evolution in the market is the combination of tissue clearing with spatial transcriptomics, shifting research from structural imaging to detailed molecular profiling within intact three-dimensional settings. This development enables scientists to map protein distribution and gene expression while preserving the spatial relationships of cellular interactions, which is essential for progress in developmental biology and immunology. The commercial success of this multi-omics strategy is demonstrated by the growth of firms creating compatible spatial profiling tools; for example, 10x Genomics reported in its February 2024 "Fourth Quarter and Full Year 2023 Financial Results" that full-year revenue reached $618.7 million, driven by the increasing use of spatial biology platforms that rely on advanced tissue preparation.

Concurrently, there is a noticeable shift toward applying tissue clearing to high-throughput 3D spheroid and organoid models, especially within pharmaceutical drug discovery workflows. Unlike whole-organ clearing, which targets anatomical mapping, this trend focuses on rapidly processing micro-tissues to assess drug toxicity and efficacy in physiologically accurate tumor models. This approach connects in vitro screening with clinical results, a need intensified by the heavy burden of oncological diseases. According to the American Cancer Society's "Cancer Facts & Figures 2024" report from January 2024, over 2 million new cancer cases are projected to be diagnosed in the United States in 2024, highlighting the critical need for these predictive preclinical models to expedite the creation of effective cancer treatments.

Key Market Players

• Logos Biosystems
• Visikol, Inc.
• LifeCanvas Technologies
• Miltenyi Biotec
• Bio-Techne
• Abcam plc
• ClearLight Biotechnologies, Inc.
• FUJIFILM Corporation
• Thermo Fisher Scientific, Inc.
• Corning Incorporated

Report Scope

In this report, the Global Tissue Clearing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Tissue Clearing Market, By Product

• Instruments
• Kits & Reagents
• Services

Tissue Clearing Market, By Application

• Neurology
• Oncology
• Cardiology
• Others

Tissue Clearing Market, By Type

• Soft Tissue
• Hard Tissue

Tissue Clearing Market, By End use

• Academic Research
• Industrial

Tissue Clearing Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Tissue Clearing Market.

Available Customizations:

Global Tissue Clearing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Tissue Clearing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Instruments, Kits & Reagents, Services)
  • 5.2.2. By Application (Neurology, Oncology, Cardiology, Others)
  • 5.2.3. By Type (Soft Tissue, Hard Tissue)
  • 5.2.4. By End use (Academic Research, Industrial)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Tissue Clearing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By Type
  • 6.2.4. By End use
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Tissue Clearing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By Type
      • 6.3.1.2.4. By End use
  • 6.3.2. Canada Tissue Clearing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By Type
      • 6.3.2.2.4. By End use
  • 6.3.3. Mexico Tissue Clearing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By Type
      • 6.3.3.2.4. By End use

7. Europe Tissue Clearing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By Type
  • 7.2.4. By End use
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Tissue Clearing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By Type
      • 7.3.1.2.4. By End use
  • 7.3.2. France Tissue Clearing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By Type
      • 7.3.2.2.4. By End use
  • 7.3.3. United Kingdom Tissue Clearing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By Type
      • 7.3.3.2.4. By End use
  • 7.3.4. Italy Tissue Clearing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By Type
      • 7.3.4.2.4. By End use
  • 7.3.5. Spain Tissue Clearing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By Type
      • 7.3.5.2.4. By End use

8. Asia Pacific Tissue Clearing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By Type
  • 8.2.4. By End use
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Tissue Clearing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By Type
      • 8.3.1.2.4. By End use
  • 8.3.2. India Tissue Clearing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By Type
      • 8.3.2.2.4. By End use
  • 8.3.3. Japan Tissue Clearing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By Type
      • 8.3.3.2.4. By End use
  • 8.3.4. South Korea Tissue Clearing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By Type
      • 8.3.4.2.4. By End use
  • 8.3.5. Australia Tissue Clearing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By Type
      • 8.3.5.2.4. By End use

9. Middle East & Africa Tissue Clearing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By Type
  • 9.2.4. By End use
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Tissue Clearing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By Type
      • 9.3.1.2.4. By End use
  • 9.3.2. UAE Tissue Clearing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By Type
      • 9.3.2.2.4. By End use
  • 9.3.3. South Africa Tissue Clearing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By Type
      • 9.3.3.2.4. By End use

10. South America Tissue Clearing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By Type
  • 10.2.4. By End use
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Tissue Clearing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By Type
      • 10.3.1.2.4. By End use
  • 10.3.2. Colombia Tissue Clearing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By Type
      • 10.3.2.2.4. By End use
  • 10.3.3. Argentina Tissue Clearing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By Type
      • 10.3.3.2.4. By End use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Tissue Clearing Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Logos Biosystems
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Visikol, Inc.
• 15.3. LifeCanvas Technologies
• 15.4. Miltenyi Biotec
• 15.5. Bio-Techne
• 15.6. Abcam plc
• 15.7. ClearLight Biotechnologies, Inc.
• 15.8. FUJIFILM Corporation
• 15.9. Thermo Fisher Scientific, Inc.
• 15.10. Corning Incorporated

16. Strategic Recommendations

17. About Us & Disclaimer